|
Real-time Estimate
Cboe BZX
14:20:17 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 64.56 USD | +1.40% |
|
-2.75% | +18.21% |
| 02:13am | AstraZeneca suffers another setback as it halts volrustomig lung cancer trial | RE |
| 11:30pm | Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,052B | |||||
| 627B | - | - | - | ||
| 441B | |||||
| 349B | |||||
| 287B |
Select your edition
All financial news and data tailored to specific country editions
